PDX Core
PDX Core
批准号:
9627117
负责人:
Michael M Ittmann
金额:
$118.94万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2024-06-30
关键词:
AddressAffectAfrican AmericanAftercareAnatomyBiometryBloodBreast Cancer PatientBreedingCancer CenterCancer PatientCaucasiansCell LineClinicalClinical MedicineCollaborationsCollectionDataDevelopmentFee-for-Service PlansFundingFutureGoalsHuman ResourcesInformaticsInformed ConsentInstitutionLaboratoriesMalignant NeoplasmsMalignant neoplasm of prostateMedicineMinorityMinority RecruitmentModelingMusNeoplasm Circulating CellsPathologicPathologistPathologyPatient TransferPatientsPharmacotherapyPilot ProjectsPopulationProstatic NeoplasmsResearch Project GrantsSCID MiceSiteTissuesTumor TissueWorkXenograft ModelXenograft procedurecancer health disparityclinical research sitecohortcollegecombatcomparativeethnic minority populationexperienceexperimental studyhealth disparityhuman modelmalignant breast neoplasmmenmortalitypathogenpatient populationracial minorityrepository
中文摘要
项目总结:
--
一项公认的研究表明,在非洲,许多癌症患者的总死亡率和死亡率都没有显著提高。
美国人和其他少数族裔和少数族裔都在美国东部。尽管美国的癌症和死亡率总体上有所下降,但美国的癌症和死亡率仍在下降。
在过去的几十年里,这些差距仍然存在。在中国,缺乏合适的汽车模式一直是一个严重的问题。
解决这些癌症和健康方面的差距。这项核心计划是贝勒医学院和中国医学院之间的一项重要合作计划。
(BCM)安德森癌症研究中心(MDACC)的首席和首席医学博士(MDACC)。他的PDX核心中心将不会招募更多患有癌症的少数族裔患者。
BCM的临床研究网站计划为循环中的肿瘤细胞(CTCs)或癌症组织捐献血液,以建立患者的基础。
衍生异种移植(PDX)。这一主要的研究重点将集中在患有前列腺癌(PC)的非裔美国人(AA)男性身上。
NMDACC的Navone教授在建立来自PC、CTC和组织的PDX方面拥有独特的、经过验证的专业知识,她说她将这样做。
在她的实验室里建立一台新的PC和PDX。这些设备将被转移到PDX和核心设备的BCM网站上,以获得额外的费用。
表征,并将数据转移到NCI、PDTC和PDX数据存储库,以及其他实验数据,作为项目1的一部分。
在今年的U54提交中,将不会被要求从少数族裔患者那里建立更多的PDX和核心项目的次要目标项目。
BCM的临床研究网站不包括PC癌症或乳腺癌(BC),重点放在影响少数人的不同癌症上。
人口。这项工作将在国家BCM和PDX核心中心完成。建立后,这些文件将不会被转移到NCI和PDTC。
PDX乳房储存库致力于进一步提升小众群体PDX在这个乳房储存库中的代表性。第三个主要目标是帮助乳房的建立。
癌症研究(BC)和PDX需要在研究和项目2中进行的一些实验。这些实验将不会收到来自路易斯博士和埃利斯博士的帮助。
在BCM会议上,他们从现有的新PDX以及新的PDX中获得了在这项新提案实施过程中产生的数据。
建立和努力是由单独的资金提供的,并且不会因为建立这个新的PDX和核心而产生额外的DBC和PDX。最后,。
在未来的几年里,我们将按照要求参与新的互联网跨网络倡议和试点项目。
英文摘要
Project Summary
It is well-established that there are significantly higher mortality rates for a number of cancers in African
Americans and other racial and ethnic minorities in the US. Despite overall reductions in cancer mortality in the
last several decades, these disparities persist. The lack of appropriate models has been a serious issue in
addressing these cancer health disparities. This Core is a collaboration between Baylor College of Medicine
(BCM) and MD Anderson Cancer Center (MDACC). The PDX Core will recruit minority patients with cancer at
BCM clinical sites to donate blood for circulating tumor cells (CTCs) or cancer tissues for establishment of patient
derived xenografts (PDXs). The major focus will be on African American (AA) men with prostate cancer (PC). Dr
Navone at MDACC has a unique, proven expertise in establishing PDXs from PC CTCs and tissues and she will
establish the PC PDXs in her laboratory. These will be transferred to the BCM site of the PDX Core for additional
characterization, transfer to the NCI PDTC PDX Repository and for experiments as part of Research Project 1
in this U54 submission. A secondary goal of the PDX Core will be to establish PDXs from minority patients at
BCM clinical sites other than PC or breast cancer (BC), with a focus on cancers disparately affecting minority
populations. This will be done at the BCM PDX Core. After establishment, these will be transferred to NCI PDTC
PDX Repository to enhance minority PDX representation in this repository. The third goal will be to set up breast
cancer (BC) PDXs for experiments in Research Project 2. These will be received from Drs. Lewis and Ellis here
at BCM from their existing PDXs as well as new PDXs generated over the course of this proposal. The BC PDX
establishment effort is separately funded and no additional BC PDXs will be generated by this PDX Core. Finally,
in future years we will participate as requested in new transnetwork initiatives and pilot projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer
-
批准号:8732393
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Michael M Ittmann
-
依托单位:
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer
-
批准号:9487872
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Michael M Ittmann
-
依托单位:
A novel oncogenic axis in African American prostate cancer
-
批准号:10158403
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Michael M Ittmann
-
依托单位:
A novel oncogenic axis in African American prostate cancer
-
批准号:10455444
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Michael M Ittmann
-
依托单位:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
-
批准号:8566162
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2012
-
负责人:Michael M Ittmann
-
依托单位:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
-
批准号:8445575
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2012
-
负责人:Michael M Ittmann
-
依托单位:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
-
批准号:8549230
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2012
-
负责人:Michael M Ittmann
-
依托单位:
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
-
批准号:8137691
-
项目类别:
-
资助金额:$69.9万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
-
批准号:8334481
-
项目类别:
-
资助金额:$67.12万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia
-
批准号:8046455
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia
-
批准号:7578441
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia
-
批准号:8233932
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
-
批准号:8541721
-
项目类别:
-
资助金额:$54.17万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia
-
批准号:7792484
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2009
-
负责人:Michael M Ittmann
-
依托单位:
Integrated Biobanking Shared Resource
-
批准号:10239119
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2007
-
负责人:Michael M Ittmann
-
依托单位:
Integrated Biobanking Shared Resource
-
批准号:10439811
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2007
-
负责人:Michael M Ittmann
-
依托单位:
Integrated Biobanking Shared Resource
-
批准号:10674547
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2007
-
负责人:Michael M Ittmann
-
依托单位:
Integrated Biobanking Shared Resource
-
批准号:10025009
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2007
-
负责人:Michael M Ittmann
-
依托单位:
Expression Analysis and Pathology CORE
-
批准号:7244460
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2006
-
负责人:Michael M Ittmann
-
依托单位:
Cytokines and FGFs in prostate cancer progression
-
批准号:6552241
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2002
-
负责人:Michael M Ittmann
-
依托单位:
海外基金